SUNNYVALE, Calif., June 15, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Patent Office has granted Patent Number 11,357,463: titled, “Target Site Selection, Entry and Update With Automatic Remote Image Annotation”, with a patent term that will expire in late 2034.
Humble & Fume Reports Wider Loss In Q2 And Slight YoY Increase In Revenue
Cannabis distributor Humble & Fume Inc. (CSE: HMBL) (OTCQX: HUMBF) announced its financial and operating results for the three and six months ended December 31, 2021.
